Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Tobira Therapeutics, Inc Proposed Ticker TBRA CUSIP 88883P101 Business Description A clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation. Lead Underwriter BMO Capital Markets Corp , JMP Securities LLC , Oppenheimer & Co Co-Managers Nomura Securities International, Inc Initial Shares 4,615,385 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.